Aardvark Therapeutics, Inc.
AARD
$6.41
-$0.16-2.44%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -47.91% | -39.71% | 49.37% | 53.41% | 64.24% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 90.30% | -27.75% | 292.19% | 1,580.59% | 562.47% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -44.28% | -39.45% | 50.92% | 56.30% | 66.42% |
|
|
|||||
| Total Current Assets | -44.28% | -39.45% | 50.92% | 56.30% | 66.42% |
| Net Property, Plant & Equipment | 19.92% | -57.17% | -51.70% | -47.80% | 397.14% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -92.08% | 157.24% | 87.48% | 1,444.40% | 1,923.15% |
| Total Assets | -44.76% | -37.21% | 51.19% | 59.10% | 69.12% |
|
|
|||||
| Total Accounts Payable | -58.74% | 75.78% | -9.83% | 567.27% | 313.07% |
| Total Accrued Expenses | -19.37% | 123.60% | 250.72% | 261.24% | 263.41% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.84% | -13.85% | 30.47% | 32.82% | 286.11% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -38.05% | 94.18% | 114.09% | 311.03% | 287.16% |
|
|
|||||
| Total Current Liabilities | -38.05% | 94.18% | 114.09% | 311.03% | 287.16% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 21.05% | -- | -- | -78.72% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -36.84% | 83.14% | 95.55% | 243.74% | 296.17% |
|
|
|||||
| Common Stock & APIC | 3.54% | 2.84% | 5,938.82% | 6,438.68% | 7,054.64% |
| Retained Earnings | -85.23% | -103.30% | -98.74% | -98.43% | -80.76% |
| Treasury Stock & Other | -- | -68.18% | -- | -- | -- |
| Total Common Equity | -45.37% | -42.27% | 295.14% | 365.03% | 423.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -45.37% | -42.27% | 295.14% | 365.03% | 423.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -45.37% | -42.27% | 47.87% | 51.87% | 61.97% |
|
|
|||||